InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Huber Martin H. Jr., Director. Officer active across 1 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 2 filings have been recorded. The latest transaction was disclosed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
016,000 shares0
Common Stock
SEC:0001562180-22-001069·
016,000 shares0
Common Stock
SEC:0001562180-22-001069:0·
2 of 2 declarations
About Huber Martin H. Jr.
Martin H. Huber Jr. serves as a Director at Syndax Pharmaceuticals Inc. In this role, he participates in the company's strategic decisions and governance. Huber brings expertise in biopharmaceuticals and research, which is crucial for Syndax's innovation. His commitment to excellence and strategic vision are assets to the board.
